Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells

DSpace/Manakin Repository

Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells

Citable link to this page

 

 
Title: Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells
Author: Xu, G. Wei; Toth, Julia I.; da Silva, Sara R.; Paiva, Stacey-Lynn; Lukkarila, Julie L.; Hurren, Rose; Maclean, Neil; Sukhai, Mahadeo A.; Bhattacharjee, Rabindra N.; Goard, Carolyn A.; Gunning, Patrick T.; Dhe-Paganon, Sirano; Petroski, Matthew D.; Schimmer, Aaron D.

Note: Order does not necessarily reflect citation order of authors.

Citation: Xu, G. W., J. I. Toth, S. R. da Silva, S. Paiva, J. L. Lukkarila, R. Hurren, N. Maclean, et al. 2014. “Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells.” PLoS ONE 9 (4): e93530. doi:10.1371/journal.pone.0093530. http://dx.doi.org/10.1371/journal.pone.0093530.
Full Text & Related Files:
Abstract: The NEDD8-activating enzyme (NAE) initiates neddylation, the cascade of post-translational NEDD8 conjugation onto target proteins. MLN4924, a selective NAE inhibitor, has displayed preclinical anti-tumor activity in vitro and in vivo, and promising clinical activity has been reported in patients with refractory hematologic malignancies. Here, we sought to understand the mechanisms of resistance to MLN4924. K562 and U937 leukemia cells were exposed over a 6 month period to MLN4924 and populations of resistant cells (R-K562MLN, R-U937MLN) were selected. R-K562MLN and R-U937MLN cells contain I310N and Y352H mutations in the NAE catalytic subunit UBA3, respectively. Biochemical analyses indicate that these mutations increase the enzyme’s affinity for ATP while decreasing its affinity for NEDD8. These mutations effectively contribute to decreased MLN4924 potency in vitro while providing for sufficient NAE function for leukemia cell survival. Finally, R-K562MLN cells showed cross-resistance to other NAE-selective inhibitors, but remained sensitive to a pan-E1 (activating enzyme) inhibitor. Thus, our work provides insight into mechanisms of MLN4924 resistance to facilitate the development of more effective second-generation NAE inhibitors.
Published Version: doi:10.1371/journal.pone.0093530
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972249/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12153026
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters